Address:
Pharmacy Discipline, Life Science School Khulna University Khulna 9208, Bangladesh
Email:
Contact:
+880-1712984884
Personal Webpage:
click hereInvestigation of two hill tract plants Tarenna campaniflora and Morinda persicifolia for antidiabetic potential and isolation of bioactive components along with in silico analysis
This project has been designed for the scientific
exploration of two hill tract medicinal plants for their antidiabetic potential
and other pharmacological properties. The number of people suffering from diabetes mellitus and its associated
pathophysiological complications has been increasing dramatically over the past
few decades, and this entails special attention towards its management. The few
conventional therapies available are either expensive or often related to
adverse effects; therefore, various traditional therapies are increasingly
sought by patients. Medicinal plants provide better alternatives as they are
generally less toxic and affordable; yet, their safety and efficacy need more
evaluation by controlled clinical studies. The proposed plants Tarenna
campaniflora and Morinda persicifolia have been selected based on
their traditional usage and because no scientific work was conducted on these
two so far. After collection, the plants’ parts will be subjected to drying,
grinding, and extraction to get crude extracts which will be then subjected to
evaluation of biological properties. The extracts will be separated with
various chromatographic techniques to isolate pure compounds whose structures will
be determined by spectroscopic analysis. Phytochemical characterization also
will be carried out by GC-MS and HPLC analysis. Molecular docking analysis of
the identified compounds would be conducted to find out molecules with better
binding affinities with pertinent receptors or enzymes. This project will
strive to explore our native natural resources to find out the source of
alternative phytochemicals having the potential to replace/support/adjunct the
current antidiabetic therapeutic moieties.
| Details | |||
| Role | Principal Investigator | ||
|---|---|---|---|
| Funding Agency | National | ||
| Awarded Date | September 2022 | ||
| Completion Date | |||